Differences in ethanol ingestion between cholecystokinin-A receptor deficient and -B receptor deficient mice

Alcohol and Alcoholism

Volumn 40, Issue 3, 2005, Pages 176-180

  Miyasaka, Kyoko ^c   Hosoya, Hiroko ^c   Takano, Saeko ^c   Ohta, Minoru ^c   Sekime, Ayako ^c   Kanai, Setsuko ^c   Matsui, Toshimitsu ^a   Funakoshi, Akihiro ^b  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; DOPAMINE 2 RECEPTOR;

ALCOHOL CONSUMPTION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AVERSION; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FLUID INTAKE; GENOTYPE; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RIGHTING REFLEX; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; WILD TYPE;

ALCOHOL DRINKING; ANIMALS; DRUG ADMINISTRATION SCHEDULE; ETHANOL; GENOTYPE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NUCLEUS ACCUMBENS; RECEPTOR, CHOLECYSTOKININ A; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, DOPAMINE D2;

EID: 18144382283     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/alcalc/agh143     Document Type: Article

References (30)

1. Baik, J. H., Picetti, R., Saiardi, A. et al. (1995) Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377, 424-428.
2. Crawley, J. N. (1991) Cholecystokinin-dopamine interactions. Trends in Pharmacological Sciences 12, 232-236.
3. Funakoshi, A., Miyasaka, K., Matsumoto, H. et al. (2000) Gene structure of human cholecystokinin (CCK) type-A receptor: Body fat content is related to CCK type A receptor gene promoter polymorphism. Federation of European Biochemical Societies 466, 264-266.
4. George, S. R., Fan, T., Ng, G. Y. et al. (1995) Low endogenous dopamine function in brain predisposes to high alcohol preference and consumption: reversal by increasing synaptic dopamine. Journal of Pharmacology and Experimental Therapeutics 273, 373-379.
5. Hamilton, M. E. and Freeman, A. S. (1995) Effects of administration of cholecystokinin into the VTA on DA overflow in nucleus accumbens and amygdala of freely moving rats. Brain Research 688, 134-142.
6. Haseba, T., Matsushita, K., Asakura, T. et al. (1993) Diminution of biological reactivity of ethanol by changing the solution structure by weak ultrasonication. Alcoholism: Clinical and Experimental Research 17, 963-967.
7. Hill, E. R., Campbell, N. J., Shaw, T. M. et al. (1987) Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists. Journal of Neuroscience 7, 2967-2977.
8. Honda, T., Wada, E., Battey, J. F. et al. (1993) Differential gene expression of CCKA and CCKB receptors in the rat brain. Molecular and Cellular Neuroscience 4, 143-154.
9. Hughes, J., Boden, P., Costall, B. et al. (1990) Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proceedings of National Academy of Sciences of the United States of America 87, 6728-6732.
10. Jones D. H. and Matus, A. I. (1974) Isolation of synaptic plasma membrane from brain by combined flotation-sedimentation density gradient centrifugation. Biochimica et Biophysica Acta 356, 276-287.
11. Kalivas, P. W. (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Research Reviews 18, 75-113.
12. Khan, Z. U., Mrzljak, L., Gutierrez, A. et al. (1998) Prominence of the dopamine D2 short isoform in dopaminergic pathways. Proceedings of National Academy of Sciences of the United States of America 65, 7731-7736.
13. Kelly, M. A., Rubinstein, M., Asa, S. L. et al. (1997) Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 19, 103-112.
14. Ladurelle, N., Durieux, C., Roques, B. P. et al. (1994) Different modifications of the dopamine metabolism in the core and shell parts of the nucleus accumbens following CCK-A receptor stimulation in the shell region. Neuroscience Letters 178, 5-10.
15. Lanca, A. J. (1994) Reduction of voluntary alcohol intake in the rat by modulation of the dopaminergic mesolimbic system: transplantation of ventral mesencephalic cell suspensions. Neuroscience 58, 359-369.
16. Maldonado, R., Saiardi, A., Vaverde, O. et al. (1997) Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388, 686-689.
17. Marshall, F. H., Barnes, S., Hughes, J. et al. (1991) Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms. Journal of Neurochemistry 56, 917-922.
18. Miyasaka, K., Kobayashi, S., Ohta, M. et al. (2002) Anxiety-related behaviors in cholecystokinin-A,B, and AB receptor gene knockout mice in the plus-maze. Neuroscience Letters 335, 115-118.
19. Miyasaka, K., Yoshida, Y., Matsushita, S. et al. (2004) Association of cholecystokinin-A receptor gene polymorphism with alcohol dependence in a Japanese population. Alcohol and Alcoholism 39, 25-28.
20. Nagata, A., Ito, M., Iwata, N. et al. (1996) G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proceedings of National Academy of Sciences of the United States of America 93, 11825-11830.
21. Phillips, T. J., Brown, K. J., Burkhart-Kasch, S. et al. (1998) Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D2 receptors. Nature Neuroscience 1, 610-615.
22. Rogers, S. W., Hughes, T. E., Hollmann, M. et al. (1991) The characterization and localization of the glutamate receptor subunit GluR1 in the rat brain. Journal of Neuroscience 11, 2713-2724.
23. Self, D. W. and Nestler, E. J. (1995) Molecular mechanisms of drug reinforcement and addiction. Annual Reviews of Neuroscience 18, 463-495.
24. Suzuki, S., Takiguchi, S., Sato, N. et al. (2001) Importance of CCK-A receptor for gallbladder contraction and pancreatic secretion: a study in CCK-A receptor knockout mice. Japanese Journal of Physiology 51, 585-590.
25. Takata, Y., Takeda, S., Kawanami, T. et al. (2002) Promoter analysis of human cholecystokinin type-A receptor gene. Journal of Gastroenterology 37, 815-820.
26. Takiguchi, S., Suzuki, S., Sato, Y. et al. (2002) Role of CCK-A receptor for pancreatic function in mice: a study in CCK-A receptor knockout mice. Pancreas 24, 276-283.
27. Usiello, A., Baik, J. H., Roug-Pont, F. et al. (2000) Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408, 199-203.
28. Wang, Y., Xu, R., Sasaoka, T. et al. (2000) Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions. Journal of Neuroscience 15, 8305-8314.
29. Wank, S. A. (1995) Cholecystokinin receptors, a review. American Journal of Physiology 269, G628-646.
30. Woodruff, G. N., Hill, D. R., Boden, P. et al. (1991) Functional role of brain CCK receptors. Neuropeptides 19, 45-56.